发明名称 |
Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor. |
摘要 |
A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form. |
申请公布号 |
ZA200504123(B) |
申请公布日期 |
2006.02.22 |
申请号 |
ZA20050004123 |
申请日期 |
2005.05.20 |
申请人 |
PFIZER PRODUCTS INC. |
发明人 |
DWAYNE THOMAS FRIESEN;DAVID KEITH LYON;TIMOTHY JOSEPH MCDERMOTT;DOUGLAS ALAN LORENZ;BRUNO CASPAR HANCOCK;RAVI MYSORE SHANKER |
分类号 |
A61K9/14;A61K9/16;A61K9/20;A61K9/24;A61K31/00;A61K31/40;A61K31/4706;A61K45/06 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|